# Guerrilla RF, Inc.: overview GUER · OTC · CIK 1832487 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/guer.md) · [Financials](/companies/guer/financials.md) · [Filings](/companies/guer/filings.md) · [Insiders](/companies/guer/insiders.md) Latest reported revenue: [$8.0m](/filings/0001437749-26-027155.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-027155). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [4,524](/filings/0001437749-25-034245.md) | [4,390 d](/filings/0001437749-26-009848.md) | [4,373](/filings/0001437749-26-016568.md) | [5,369](/filings/0001437749-26-027155.md) | [6,288](/filings/0001437749-25-034245.md) | [6,700 d](/filings/0001437749-26-009848.md) | [6,462](/filings/0001437749-26-016568.md) | [8,012](/filings/0001437749-26-027155.md) | | Gross margin | % | [65.3%](/filings/0001437749-25-034245.md) | [60.4% d](/filings/0001437749-26-009848.md) | [61.1%](/filings/0001437749-26-016568.md) | [64.9%](/filings/0001437749-26-027155.md) | [67.5%](/filings/0001437749-25-034245.md) | [66.4% d](/filings/0001437749-26-009848.md) | [69.9%](/filings/0001437749-26-016568.md) | [70.9%](/filings/0001437749-26-027155.md) | | Operating margin | % | [(57.7%)](/filings/0001437749-25-034245.md) | [(71.0%) d](/filings/0001437749-26-009848.md) | [(72.3%)](/filings/0001437749-26-016568.md) | [(25.2%)](/filings/0001437749-26-027155.md) | [(3.2%)](/filings/0001437749-25-034245.md) | [0.8% d](/filings/0001437749-26-009848.md) | [(0.7%)](/filings/0001437749-26-016568.md) | [12.0%](/filings/0001437749-26-027155.md) | | Net margin | % | [(159.2%)](/filings/0001437749-25-034245.md) | [35.9% d](/filings/0001437749-26-009848.md) | [(81.0%)](/filings/0001437749-26-027155.md) | [(8.8%)](/filings/0001437749-26-027155.md) | [(10.3%)](/filings/0001437749-25-034245.md) | [(34.7%) d](/filings/0001437749-26-009848.md) | [17.4%](/filings/0001437749-26-027155.md) | [(27.9%)](/filings/0001437749-26-027155.md) | | Diluted EPS | $ per share | not reported | not reported | [(0.34)](/filings/0001437749-26-016568.md) | not reported | not reported | not reported | [0.06](/filings/0001437749-26-016568.md) | not reported | | Free cash flow | $k | [(1,965) d](/filings/0001437749-25-034245.md) | [(2,941) d](/filings/0001437749-26-009848.md) | [(2,311)](/filings/0001437749-26-016568.md) | [(1,594) d](/filings/0001437749-26-027155.md) | [286 d](/filings/0001437749-26-009848.md) | [896 d](/filings/0001437749-26-009848.md) | [(1,317)](/filings/0001437749-26-016568.md) | [2,265 d](/filings/0001437749-26-027155.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [10.5](/filings/0001437749-23-005378.md) | [11.6](/filings/0001437749-24-010107.md) | [15.1](/filings/0001437749-25-009538.md) | [20.1](/filings/0001437749-26-009848.md) | [22.7](/filings/0001437749-26-009848.md) | | Gross margin | % | [58.6%](/filings/0001437749-23-005378.md) | [58.3%](/filings/0001437749-24-010107.md) | [57.1%](/filings/0001437749-25-009538.md) | [63.7%](/filings/0001437749-26-009848.md) | [65.3%](/filings/0001437749-26-009848.md) | | Operating margin | % | [(35.0%)](/filings/0001437749-23-005378.md) | [(95.9%)](/filings/0001437749-24-010107.md) | [(85.7%)](/filings/0001437749-25-009538.md) | [(43.6%)](/filings/0001437749-26-009848.md) | [(20.5%)](/filings/0001437749-26-009848.md) | | Net margin | % | [(27.1%)](/filings/0001437749-23-005378.md) | [(103.7%)](/filings/0001437749-24-010107.md) | [(105.9%)](/filings/0001437749-25-009538.md) | [(53.5%)](/filings/0001437749-26-009848.md) | [(30.7%)](/filings/0001437749-26-009848.md) | | Diluted EPS | $ per share | [(0.24)](/filings/0001437749-22-007905.md) | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(5.2)](/filings/0001437749-23-005378.md) | [(9.8)](/filings/0001437749-24-010107.md) | [(13.6)](/filings/0001437749-25-009538.md) | [(7.0)](/filings/0001437749-26-009848.md) | [(2.8)](/filings/0001437749-26-009848.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/guer/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIVERSIFIED TRUST CO](/funds/1479844.md) | 2026-06-30 | $63.3k | 22,754 | | Reduced −10,740 | ## Recent filings [All 303 filings](/companies/guer/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-12 | 08:01 ET | [10-Q](/filings/0001437749-26-027155.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027155 | | 2026-08-06 | 08:00 ET | [8-K](/filings/0001437749-26-026050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026050 | | 2026-06-05 | 10:29 ET | [8-K](/filings/0001437749-26-019680.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-019680 | | 2026-05-13 | 09:49 ET | [10-Q](/filings/0001437749-26-016568.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016568 | | 2026-05-06 | 08:00 ET | [8-K](/filings/0001437749-26-015017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015017 | | 2026-04-10 | 12:43 ET | [DEF 14A](/filings/0001437749-26-011975.md) | Proxy statement, period 2026-06-03 | 0001437749-26-011975 | | 2026-03-26 | 08:01 ET | [10-K](/filings/0001437749-26-009848.md) | Annual report, period 2025-12-31 | 0001437749-26-009848 | | 2026-03-26 | 07:59 ET | [8-K](/filings/0001437749-26-009847.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009847 | | 2025-12-31 | 17:28 ET | [8-K](/filings/0001437749-25-039100.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-039100 | | 2025-11-12 | 08:02 ET | [10-Q](/filings/0001437749-25-034245.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034245 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009848.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2e1f6c0f-bb38-4cd1-a70d-93d2626a986c) ## About the filer - CIK: 1832487 - Tickers: GUER - Exchange: OTC - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.